4.3 Article

Radiosynthesis and in vivo evaluation of a new positron emission tomography radiotracer targeting bromodomain and extra-terminal domain (BET) family proteins

Journal

NUCLEAR MEDICINE AND BIOLOGY
Volume 84-85, Issue -, Pages 96-101

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2020.04.003

Keywords

Epigenetic; Bromodomain; PET; Radiorracer; Imaging

Funding

  1. National Institute of Neurological Disorders and Stroke (NINDS) [R01NS108115]
  2. Bluefield Project to Cure FTD
  3. China Scholarship Council (CSC)
  4. Stuart & Suzanne Steele MGH Research Scholars Program
  5. Martinos Center

Ask authors/readers for more resources

Introduction: Bromodomain and extra-terminal domain (BET) family proteins play a vital role in the epigenetic regulation process by interacting with acetylated lysine (Ac-K) residues in histones. BET inhibitors have become promising candidates to treat various diseases through the inhibition of the interaction between BET bromodomains and Ac-K of histone tails. With a molecular imaging probe, noninvasive imaging such as positron emission tomography (PET) can visualize the distribution and roles of BET family proteins in vivo and enlighten our understanding of BET protein function in both healthy and diseased tissue. Methods: We radiolabeled the potent BET inhibitor INCB054329 by N-methylation to make [C-11]PB003 as a BET PET radiotracer. The bioactivity evaluation of unlabeled P0003 in vitro was performed to confirm its binding affinity for BRDs, then the PET/CT imaging in rodents was performed to evaluate the bioactivity of [C-11]PB003 in vivo. Results: In our in vitro evaluation, PB003 showed a high BET binding affinity for BRDs (K-d = 2 nM, 12 nM, and 1.2 nM for BRD2, BRD3, and BRD4, respectively). In vivo PET/CT imaging demonstrated that [C-11]PB003 has favorable uptake with appropriate kinetics and distributions in main peripheral organs. Besides, the blockade of [C-11]PB003 binding was found in our blocking study which indicated the specificity of [ II C]PB003. However, the BBB penetration and brain uptake of [C-11]PB003 was limited, with only a maximum 02% injected dose/g at similar to 2 min post-injection. Conclusion: The imaging results in rodents in vivo demonstrate that [C-11]PB003 binds to BET with high selectivity and specificity and has favorable uptake in peripheral organs. However, the low brain uptake of [C-11]PB003 limits the visualization of brain regions indicating the efforts are still needed to discover the new BET imaging probes for brain visualization. (C) 2020 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available